Search for: "LILLY v. WYETH"
Results 21 - 40
of 112
Sort by Relevance
|
Sort by Date
21 Jun 2012, 4:30 am
Eli Lilly, 2011 U.S. [read post]
7 May 2012, 5:00 am
Eli Lilly & Co., 489 F. [read post]
4 Mar 2012, 9:02 am
Wyeth, Inc., 500 F.Supp. 2d 1048, 1056-57 (S.D.Ill. 2007), aff’d, 556 F.3d 596 (7th Cir. 2009). [read post]
28 Oct 2011, 7:00 am
Eli Lilly & Co., 2009 WL 5216930, at *12 (E.D.N.Y. [read post]
27 Oct 2011, 4:24 am
The Supreme Court held in Wyeth v. [read post]
13 Jul 2011, 3:04 am
(IP Watch) BRIC health ministers’ meeting – Beijing declaration (KEI) “Lilly’s pipeline remains incapable of replacing patent-related losses” (IPBiz) A new book – and a competition! [read post]
9 Jun 2011, 10:02 am
Eli Lilly & Co., 2009 WL 5216930, at *12 (E.D.N.Y. [read post]
7 Jun 2011, 11:06 am
” Eli Lilly, 199 F.3d at 1568 (quoting Fiers v. [read post]
2 Jun 2011, 12:46 pm
Wyeth Inc., 488 F. [read post]
18 May 2011, 12:33 am
Highlights this week included: US: FTC alleges companies were asleep at the wheel when they failed to report settlement agreements on Ambien CR; Commission uses the opportunity to provide industry guidance – and a warning (FDA Law Blog) (GenericsWeb) Gemzar (Gemcitabine) – US: Certiorari denied in Eli Lilly v. [read post]
28 Apr 2011, 3:18 pm
Brown v. [read post]
24 Feb 2011, 1:49 pm
Wyeth-Ayerst Laboratories, 1999 WL 33548540, at *1 (S.D. [read post]
3 Feb 2011, 2:11 pm
Wyeth, 876 N.E.2d 740, 756 (Ill. [read post]
31 Jan 2011, 8:10 am
Bon Tool, to Wyeth v. [read post]
31 Jan 2011, 8:10 am
Bon Tool, to Wyeth v. [read post]
25 Jan 2011, 10:58 pm
General GSK critiques Anti-Counterfeiting Trade Agreement (IP Watch) WHO Members show dismay at delay on Counterfeit Medicines Group (IP Watch) WHO R&D financing committee approved with controversial industry expert (IP Watch) (KEI) (KEI) (KEI) BioCentury this week explores orphan drugs with HP&M attorney and NORD Board Chair (FDA Law Blog) EU: Paediatric extensions and transitional provisions: a question of timing (The SPC Blog) India: Patent Office continue refusing pharmaceutical… [read post]
29 Dec 2010, 12:54 pm
Wyeth, Inc. v. [read post]
6 Oct 2010, 4:22 am
(profitability through simplicity) US: Yeda Appeals Board decision favoring Abbott in TBP-II interference (Holman’s Biotech IP Blog) US: Jury finds Scruggs wilfully infringed Monsanto patents, awards at least $9 million in damages (Holman’s Biotech IP Blog) US: Marcy Kaptur’s bill to create a compulsory license for patented seeds: the Seed Availability and Competition Act of 2009 (KEI) US: Glaxosmithkline Biologicals seeks review of BPAI decision concerning isolated protein from B… [read post]
28 Sep 2010, 3:14 pm
Eli Lilly & Co. [read post]
15 Sep 2010, 2:40 am
(Afro-IP) Africa: Giving consumers power in the battle against counterfeits (Afro-IP) Australia: Review Four Corners’ ‘Body Corporate’ program on gene patenting (Patentology) India: Roche and Novartis, finally, manage to defend their patents in oppositions filed by Cipla (Spicy IP) South Africa: San people push for new legislation – demand protection for indigenous knowledge and IP including medicinal remedies derived from plants including Hoodia (Afro-IP) US: PHOSITA:… [read post]
